CN1089002C - Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease - Google Patents
Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease Download PDFInfo
- Publication number
- CN1089002C CN1089002C CN99126606A CN99126606A CN1089002C CN 1089002 C CN1089002 C CN 1089002C CN 99126606 A CN99126606 A CN 99126606A CN 99126606 A CN99126606 A CN 99126606A CN 1089002 C CN1089002 C CN 1089002C
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- patent medicine
- parts
- chinese
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a Chinese patent medicine for treating ulceratiue stomatitis and Behcet's syndrome. The Chinese patent medicine for oral administration is prepared from ginseng, pangolin, yam, astragalus root, honeysuckle flower, mint, Chinese caterpillar fungus, cassia bark, saffron, etc. as raw materials. In general, the Chinese patent medicine has the functions of strengthening the spleen, invigorating qi, removing toxin, promoting wound healing, relieving inflammation, removing turgescence, eliminating putrescence, generating muscles, disperse the liver energy, regulating vital energy, activating blood circulation to dissipate blood stasis, and clearing dampness, and the present invention accords with the Chinese medicine pathogenesis of ulceratiue stomatitis. The Chinese patent medicine treats both manifestation and root cause of diseases and has the advantages of obvious clinical curative effect, high effective rate, no toxicity and harm to a human body.
Description
The present invention relates to a kind of medicine for the treatment of oral ulcer and behcets disease, relate in particular to a kind of Chinese patent medicine for the treatment of oral ulcer and behcets disease.
Oral ulcer is the commonly encountered diseases of department of eye, its ulcer is sent out in positions such as oral mucosa, lip, tongue, gingiva, pharynx, larynxs well, has in batches the characteristics of outbreak repeatedly, and at present main Therapeutic Method is to take multivitamin, severe patient is taken the sugar skin hormone treatment, and curative effect can not be satisfactory.
Because people do not understand the importance of oral ulcer treatment, there is considerable patient in time not treat, and causing concurrent behcets disease, secondly the clinical symptoms of behcets disease is skin lesion, arthritis and arthralgia, lower limb vein thrombus etc. based on oral cavity, reproduction ulcer and ophthalmia.Behcets disease is immune a kind of repeated relapsing disease, and the medicine of integrative therapy primary disease is a lot of at present, but effect is undesirable, easily recurrence.
Purpose of the present invention aims to provide a kind of curative effect height, the treatment oral ulcer that is difficult for recurrence and the Chinese patent medicine of behcets disease.
Solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of motherland's medical science to oral ulcer and behcets disease, from motherland's medical treasure-house, filter out invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, and antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is let out damp and hot Chinese patent medicine clearly, makes oral Chinese patent medicine by traditional Chinese medical science prescription theory.
Chinese patent medicine of the present invention is made (consumption is a weight portion) by following traditional Chinese medicine raw:
Radix Ginseng 12-18 part Squama Manis 3-7 part Rhizoma Dioscoreae 8-12 part
Radix Astragali 17-23 part Flos Lonicerae 17-23 part Herba Menthae 17-23 part
Cordyceps 8-12 part Cortex Cinnamomi 17-23 part Stigma Croci 12-18 part
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
The optimum weight proportioning of Chinese patent medicine of the present invention is:
10 parts of 5 portions of Rhizoma Dioscoreaes of 15 parts of Squama Maniss of Radix Ginseng
20 parts of 20 portions of Herba Menthaes of 20 portions of Flos Loniceraes of the Radix Astragali
15 parts of 20 parts of Stigma Crocis of 10 portions of Cortex Cinnamomis of Cordyceps
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
The inventor thinks that oral ulcer is many because of long-pending on the heart-fire, and spleen-heat is wet contains hyperactivity of fire caused by deficiency of YIN, fumigate in mouth, the corruption of intenseness of heat meat is due to the immunologic hypofunction, to the untimely treatment of oral ulcer, easy concurrent behcets disease therefore should be with invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is let out the damp and hot principles of formulating prescriptions that are clearly.
Flos Lonicerae, Herba Menthae heat-clearing and toxic substances removing are held back skin ulcer in the side, Rhizoma Dioscoreae spleen invigorating QI invigorating dampness removing, Squama Manis, Stigma Croci blood circulation promoting and blood stasis dispelling collateral dredging, the Radix Astragali, Radix Ginseng, Cordyceps using tonifying Qi reinforcing lungs, human body immunity improving function, Cortex Cinnamomi simultaneously using both cold and hot drugs, let the fire back to its origin is made a general survey of full side, coordinates mutually, the common cooperation, play invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is let out damp and hot effect clearly.
For showing the therapeutic effect of Chinese patent medicine of the present invention to oral ulcer and behcets disease, the present invention has carried out system's clinical observation to 311 routine intractable oral cavity ulcers and 311 routine behcets diseases, and its curative effect statistical result is as follows:
Contrast before and after the treatment of table 1 oral ulcer
After treating before the symptom treatment
Symptom mild symptoms symptom no change sx effective percentage (%) is arranged
Gingival mucosa ulcer 242 242 00 100
Buccal mucosa ulcer 292 256 36 0 87.67
Mucosa of lip ulcer 248 246 20 99.19
Periglottis ulcer 86 80 60 93.02
Pharyngolaryngeal mucosa ulcer 152 140 12 0 92.11
Contrast before and after the treatment of table 2 behcets disease
After treating before the symptom treatment
Symptom mild symptoms symptom no change sx effective percentage (%) is arranged
Repeated relapsing aphtha 311 282 29 0 90.68
Eye damages 292 256 36 0 87.67
Genitals damages 248 246 20 99.19
Arthritis and arthralgia 86 80 60 93.02
Varicose veins of the lower extremity 242 242 00 100
Skin lesion 152 140 12 0 92.11
Wherein intractable oral cavity ulcer age of onset reckling is 9 years old, the maximum 70 years old, and medical history (discovery oral ulcer) half a year---20 years, male's 116 examples, women's 195 examples; Behcets disease age of onset reckling 15 years old, the maximum 72 years old, medical history (discovery behcets disease) a year---21 years, male's 120 examples, women's 191 examples.
Show that from above-mentioned clinical statistics data Chinese patent medicine of the present invention is to disease controlling, alleviate patient's symptom and the complication effect is obvious.
The present invention has following advantage:
1, to select natural Chinese medicinal herb for use be raw material in the present invention, each component meets the pharmaceutical control law regulation, and full side's compatibility has invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, let out damp and hot effect clearly, meet the traditional Chinese medical science the pathogenetic understanding of oral ulcer, and nontoxic to human body.
2, the present invention need not decoct taking convenience.
3, treating both the principal and secondary aspects of a disease of the present invention, clinical efficacy is remarkable, and effective percentage reaches 90.68%.
Embodiment 1:
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
Radix Ginseng 15kg Squama Manis 5kg Rhizoma Dioscoreae 10kg
Radix Astragali 20kg Flos Lonicerae 20kg Herba Menthae 20kg
Cordyceps 10kg Cortex Cinnamomi 20kg Stigma Croci 15kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Manufacture method: it is clean earlier will above-mentioned nine flavor Chinese medicines to choose the decontamination choosing, and oven dry is ground into fine powder, sieves, and abundant mixing reinstalls in the 0.3g capsule and gets final product.With cobalt 60 radiation sterilizations,, can make in the capsule 2-3 and preserve well with favorable moth-proof or fungus growth.
Function with cure mainly: invigorating the spleen and benefiting QI, the detoxifcation hold back skin ulcer, be used for recurrent oral ulceration, mucosal ulcer such as tongue, cheek, lip, pharynx, larynx, gum.
Usage and consumption: oral, one time 5, three times on the one, one after each meal.
Specification: every dress 0.3g.
Storage: sealing, put shady and cool place.
Embodiment 2:
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
Radix Ginseng 12kg Squama Manis 3kg Rhizoma Dioscoreae 8kg
Radix Astragali 17kg Flos Lonicerae 17kg Herba Menthae 17kg
Cordyceps 8kg Cortex Cinnamomi 17kg Stigma Croci 12kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Embodiment 3:
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
Radix Ginseng 18kg Squama Manis 7kg Rhizoma Dioscoreae 12kg
Radix Astragali 23kg Flos Lonicerae 23kg Herba Menthae 23kg
Cordyceps 12kg Cortex Cinnamomi 23kg Stigma Croci 18kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of oral ulcer and behcets disease is characterized in that: be made up of Radix Ginseng 12-18 part, Squama Manis 3-7 part, Rhizoma Dioscoreae 8-12 part, Radix Astragali 17-23 part, Flos Lonicerae 17-23 part, Herba Menthae 17-23 part, Cordyceps 8-12 part, Cortex Cinnamomi 17-23 part, Stigma Croci 12-18 part.
2, the Chinese patent medicine of treatment oral ulcer according to claim 1 and behcets disease is characterized in that: be made up of for 15 parts 15 parts of Radix Ginsengs, 5 parts of Squama Maniss, 10 parts of Rhizoma Dioscoreaes, 20 parts of the Radixs Astragali, 20 parts of Flos Loniceraes, 20 parts of Herba Menthaes, 10 parts of Cordyceps, 20 parts of Cortex Cinnamomis, Stigma Croci.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99126606A CN1089002C (en) | 1999-12-22 | 1999-12-22 | Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99126606A CN1089002C (en) | 1999-12-22 | 1999-12-22 | Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1257732A CN1257732A (en) | 2000-06-28 |
| CN1089002C true CN1089002C (en) | 2002-08-14 |
Family
ID=5284476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99126606A Expired - Fee Related CN1089002C (en) | 1999-12-22 | 1999-12-22 | Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1089002C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1306945C (en) * | 2002-08-12 | 2007-03-28 | 董学巧 | Chinese Medicinal prescription for treating oral ulcer and its production process |
| CN104147247B (en) * | 2014-09-04 | 2015-03-25 | 尹光山 | Medicine for treating Yang-deficiency Qi-weakness type recurrent oral ulceration |
| CN110448688A (en) * | 2019-09-11 | 2019-11-15 | 徐州生物工程职业技术学院 | A kind of lysozyme formulation, preparation method and application |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1203807A (en) * | 1998-07-24 | 1999-01-06 | 兰金初 | Medicine for curing recurrent stomatocace and Behcet's syndrome |
| CN1207945A (en) * | 1998-08-18 | 1999-02-17 | 李永刚 | Balsam pear-natural indig medicine powder |
-
1999
- 1999-12-22 CN CN99126606A patent/CN1089002C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1203807A (en) * | 1998-07-24 | 1999-01-06 | 兰金初 | Medicine for curing recurrent stomatocace and Behcet's syndrome |
| CN1207945A (en) * | 1998-08-18 | 1999-02-17 | 李永刚 | Balsam pear-natural indig medicine powder |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1257732A (en) | 2000-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101053632A (en) | Traditional Chinese medicine for treating thromboangitis obliterans | |
| CN101066445A (en) | Chinese medicine prepn for curing gastropathy radically | |
| CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN1089002C (en) | Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease | |
| CN1864733A (en) | Chinese proprietary medicine for treating oral cavity inflammation | |
| CN1208646A (en) | Medicine for treating gastrointestinal ulcer and gastritis | |
| CN1149468A (en) | Powder for laryngopharyngitis | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN1163251C (en) | Weishukang for treating gastrosis | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1290545C (en) | Medicine for curing coronary heart disease | |
| CN1240426C (en) | Prepared Chinese medicine for treating ulcerative stomatitis | |
| CN1167455C (en) | Medicine for treating acne and its preparing process | |
| CN106552134A (en) | A kind of Chinese medicinal formulae for treating periodontal disease | |
| CN1170572C (en) | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof | |
| CN1085100A (en) | A kind of specific tooth disease medicine | |
| CN1296034C (en) | Halitosis removing toothpaste | |
| CN1261128C (en) | Medicine for treating burn and scald, preparing method thereof | |
| CN1281257C (en) | Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis | |
| CN100384448C (en) | Aphtha treating Chinese medicinal preparation | |
| CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
| CN1281255C (en) | Medication for treating ulcer of lower limb of patients of skin disease and diabetic, and preparation method | |
| CN106822258B (en) | Traditional Chinese medicine composition for treating toothache and preparation thereof | |
| CN1253195C (en) | Anti-age capsule of traditional Chinese medicine and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |